FDA Adds Devices To Breakthrough Program, Cardiology Devices Still Out Front

The US FDA has increased the number of devices cleared through its breakthrough program, which the agency established in 2015 to expedite access to products aimed at treating life-threatening and debilitating diseases.

More from Medtech Insight

More from Approvals